While Humana Inc has overperformed by 0.02%, investors are advised to look at stock chart patterns for technical insight. Within its last year performance, HUM rose by 16.37%, with highs and lows ranging from $315.35 to $206.87, whereas the simple moving average jumped by 13.24% in the last 200 days.
On September 22, 2025, Evercore ISI started tracking Humana Inc (NYSE: HUM) recommending In-line. A report published by Raymond James on May 01, 2025, Upgraded its rating to ‘Outperform’ for HUM. BofA Securities also Upgraded HUM shares as ‘Neutral’, setting a target price of $308 on the company’s shares in a report dated November 06, 2024. Bernstein October 08, 2024d its ‘Mkt Perform’ rating to ‘Outperform’ for HUM, as published in its report on October 08, 2024. TD Cowen’s report from October 07, 2024 suggests a price prediction of $261 for HUM shares, giving the stock a ‘Hold’ rating. Jefferies also rated the stock as ‘Hold’.
Analysis of Humana Inc (HUM)
Investors in Humana Inc will get a return regardless of how the company performs over the next quarter since the company’s dividend stands at $3.54 per share. Further, the quarter-over-quarter increase in sales is 9.64%, showing a positive trend in the upcoming months.
One of the most important indicators of Humana Inc’s future performance is equity, which can be evaluated using several well-rounded types of analysis and research techniques. The goal here is to ensure that your current return on equity of 9.03% is sufficient for you to turn a profit off your investment.
For any stock, average volume can also provide valuable insight into volatility, and HUM is recording 1.92M average volume. On a monthly basis, the volatility of the stock is set at 4.97%, whereas on a weekly basis, it is put at 7.78%, with a gain of 13.48% over the past seven days. Furthermore, long-term investors anticipate a median target price of $290.70, showing decline from the present price of $295.25, which can serve as yet another indication of whether HUM is worth investing in or should be passed over.
How Do You Analyze Humana Inc Shares?
The Healthcare Plans market is dominated by Humana Inc (HUM) based in the USA. When comparing Humana Inc shares with other companies under Healthcare, the P/E value is an influential factor to note. This is because it represents an indication of the future growth of the company in terms of investors’ expectations. Ultimately, the value of the latter should demonstrate steady, rapid growth, which is an accurate measure of the company’s progress. In addition to the value of 22.66, there is a growth in quarterly earnings of -19.79%.
Along with the fundamentals, it is also important to consider how many employees own shares of the company. This is because the values should be in line with investors’ expectations. As such, the current holdings of company stock inside the company are set at 0.23%. This can enable you to see the extent to which executives own the company’s stock. As opposed to executive stock, institutional ownership accounts for 95.36% of the company’s shares, contributing to an indication of company value, since large shareholders may signify strength within the organization.
